Longaeva Partners’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.99M Buy
+226,587
New +$3.01M 0.06% 218

Other funds holding ENTA

Longaeva Partners's ENTA Position: Q3 2026 in Review

Longaeva Partners opened a new position in Enanta Pharmaceuticals (ENTA) in Q3 2026: 226,587 shares worth $2.99M. The stake represents 0.06% of the portfolio and ranks #218 among its holdings.

127 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.

  • Longaeva Partners held 226,587 shares of Enanta Pharmaceuticals worth $2.99M as of Q3 2026.
  • Enanta Pharmaceuticals was a new Longaeva Partners position in Q3 2026.
  • Enanta Pharmaceuticals made up 0.06% of Longaeva Partners's portfolio in Q3 2026, its #218 holding.
  • 127 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.